Moderna Stock No-Brainer After FDA Win: Buy or Not?
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesA recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
In June, Netflix faced a sharp pullback as investors weighed slowing subscriber growth against rising content costs a...
Could SpaceX expand from rockets to handheld devices? This article examines the idea of spacex planning make smartpho...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
Nvidia delivered a record quarterly revenue of $68.1 billion and projected $78 billion for the coming quarter, driven...
Optics names retreat after a one-day surge driven by sector optimism. Credo Drops 15%, Lumentum slides 11%, AAOI decl...
QuantumScape has fallen hard in early 2026. This guide walks you through what would move the stock higher, what could...
Biotech stocks rally as late-stage trial data and regulatory milestones boost investor confidence. Analysts say the b...
In a bid to curb pump prices, the Trump administration announced a temporary waiver of the Jones Act. Early market re...
GameStop delivers a strong Q4 with a record cash balance and earnings beat, but the CEO’s silence on any megadeal kee...
Snowflake jumped roughly 9% in early trading, outpacing ServiceNow as investors chase AI-driven growth. The cloud sof...
U.S. money supply has swollen to $22.7 trillion, renewing worries that easy liquidity is inflating a fresh market bub...